BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $4,365,000 | +21.0% | 38,924 | 0.0% | 2.42% | +14.5% |
Q3 2020 | $3,608,000 | +18.8% | 38,924 | 0.0% | 2.12% | +14.2% |
Q2 2020 | $3,036,000 | +33.4% | 38,924 | 0.0% | 1.85% | -15.9% |
Q1 2020 | $2,276,000 | -27.0% | 38,924 | 0.0% | 2.20% | -19.9% |
Q4 2019 | $3,118,000 | – | 38,924 | – | 2.75% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |